A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...
Add Yahoo as a preferred source to see more of our stories on Google. PSA stands for prostate-specific antigen, a substance naturally produced in prostate tissue. A small amount of PSA regularly ...
Noninvasive monitoring of low-grade prostate cancer with a urinary biomarker test could reduce the need for biopsies and serial imaging, according to a study ...
Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review ...
To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies.
TEM is integrating externally developed AI pathology into its ecosystem to improve risk prediction and personalize prostate ...
WASHINGTON D.C. (WPVI) -- The Preventive Services Task Force is changing recommendations that can affect millions of middle-aged men. Five years ago, it opposed routine screening for prostate ...
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, today announced the clinical launch of the ArteraAI Prostate Test (mHSPC). The CLIA-certified and CAP-accredited prognostic ...
A new study may have found a potentially easier, less disruptive and more effective way to treat the second leading cause of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results